We are live on ! Find out more
SYNB

Putnam BioRevolution ETF
SYNB

Delisted

SYNB was delisted on the 13th of November, 2025.

Back to rankings

3 hedge funds and large institutions have $3.88M invested in Putnam BioRevolution ETF in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

2% more capital invested

Capital invested by funds: $3.82M → $3.88M (+$57.7K)

0.15% less ownership

Funds ownership: 77.81% → 77.67% (-0.15%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$209K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$216K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
Putnam Investments
Massachusetts
$3.47M – – –
Jane Street
2
Jane Street
New York
$211K +$209K +7,622 New
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$199K -$216K -7,885 -52%

SYNB Hedge Fund Activity: Q2 2023 in Review

3 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q2 2023, worth a combined $3.88M — up 1.5% from $3.82M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SYNB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $209K. The largest seller was Royal Bank of Canada, cutting an estimated $216K.

  • 3 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q2 2023, up from 2 in Q1 2023.
  • Funds reported $3.88M of Putnam BioRevolution ETF stock for Q2 2023, up 1.5% quarter-over-quarter.
  • 1 fund opened new Putnam BioRevolution ETF positions in Q2 2023 and 0 closed out, a net change of +1 holder.
  • The largest Putnam BioRevolution ETF buyer in Q2 2023 was Jane Street, an estimated $209K added.
  • The largest Putnam BioRevolution ETF seller in Q2 2023 was Royal Bank of Canada, an estimated $216K sold.

Based on aggregated 13F filings for Q2 2023.